Author:
Bai Changsen,Wang Chaomin,Hua Jialei,Zhao Na,Li Tong,Li Wenxin,Niu Wenhao,Zhong Benfu,Yang Shuaini,Chen Chunda,Zhao Gang,Qiu Li,Jiang Zhansheng,Li Lifang,Li Yueguo,Wang Hailong
Reference39 articles.
1. Cancer Treatment and Survivorship Statistics, 2022, CA: A Cancer Journal for Clinicians;Miller,2022
2. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring;Li;Mol. Cancer,2022
3. Recent advances in the management of lung cancer;Jones;Clin. Med. (Lond.),2018
4. Managing resistance to immune checkpoint inhibitors in lung cancer: treatment and novel strategies;Passaro;J. Clin. Oncol.,2022
5. M.S. von Itzstein, D.E. Gerber and J.D. Minna, Contemporary lung cancer screening and the promise of blood-based biomarkers, Cancer Res. 81, 3441–3443 doi: https://doi.org/10.1158/0008-5472.can-21-0706.